NIH, Fox Foun­da­tion al­lies with bio­phar­mas on $24M Parkin­son's project; FDA ac­cepts Ther­a­vance/My­lan NDA for COPD drug

→ The NIH is team­ing up with The Michael J. Fox Foun­da­tion and a group of life sci­ences com­pa­nies on a $24 mil­lion ini­tia­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA